RESUMO
The pharmacokinetics of N1-acetylsulphamethoxazole and N4-acetylsulphamethoxazole in man are described. N1-Acetylsulphamethoxazole is deacetylated to sulphamethoxazole and acetylated to N4-acetylsulphamethoxazole. N4-Acetylsulphamethoxazole is excreted almost unchanged in the urine. The renal excretion rate is independent of the urine flow and urinary pH. N4-Acetylsulphonamides are less lipid soluble and more acidic than their corresponding parent sulphonamides.
Assuntos
Sulfametoxazol/análogos & derivados , Acetilação , Acetiltransferases/metabolismo , Creatinina/metabolismo , Feminino , Meia-Vida , Humanos , Cinética , Lipídeos , Masculino , Fenótipo , Solubilidade , Sulfametoxazol/metabolismoRESUMO
The pharmacokinetics of sulphamethizole, sulphamethoxazole, sulphadiazine, sulphapyridine and sulphadimidine have been studied in man. Renal clearance values of the metabolite N4-acetylsulphonamide are 6 to 20 times higher than those of the corresponding parent compound. The renal clearance of sulphonamides is dependent on the urine flow. N4-Acetylsulphonamide concentration-time profiles for plasma and urine have been constructed for the sulphonamides. The percentage N4-acetylsulphonamide-time profiles for plasma are excellent tools for establishing the acetylator phenotype, while those constructed from urine samples are less useful. Evidence is obtained that sulphadimidine is metabolically processes by 2 different isoenzymes, while sulphadiazine, sulphapyridine and sulphamethoxazole are processes by 1 acetylating isoenzyme. Sulphamethizole is acetylated to very little extent.
Assuntos
Sulfonamidas/metabolismo , Acetilação , Humanos , Rim/metabolismo , Cinética , Fenótipo , Sulfonamidas/sangue , Sulfonamidas/urina , Fatores de TempoRESUMO
1. A one-compartment pharmacokinetic model was developed in which a drug underwent two successive metabolical reactions (for example, metabolism followed by conjugation) and free drug and both metabolites were excreted.2. Techniques were described whereby graphical estimates of the first-order rate constants may be derived from cumulative excretion data on the drug and its metabolites. Computer simulation techniques were used to show that the experimental data permit reasonably accurate estimation of the rate constants of the model by graphical and computer methods.3. Tritiated methyl orange (2 mg) was administered to five groups of six rats with biliary cannulation. The bile produced by each animal was collected at hourly intervals for 6 h and the amounts of methyl orange and its metabolites, 4'sulpho-4-methylaminoazobenzene and 4'sulpho-4-aminoazobenzene, determined by thin layer chromatography and radioactive counting techniques.4. The data were analysed graphically and with an iterative digital computer programme to yield the first-order rate constants for the successive demethylation steps in the metabolism of methyl orange. The removal of the first methyl group had a rate constant of 0.684+/-0.142 h(-1) (+/-S.D.) and the second methyl group 1.00+/-0.302 h(-1). The rate constant for biliary excretion of the free methyl orange was 0.164+/-0.042 h(-1), for the monomethyl derivative 0.672+/-0.461 h(-1), and for the demethylated metabolite 6.413+/-3.222 h(-1).
Assuntos
Compostos Azo/metabolismo , Bile/metabolismo , Metilação , Ácidos Sulfônicos/metabolismo , Animais , Compostos Azo/análise , Bile/análise , Cromatografia em Camada Fina , Computadores , Géis , Cinética , Masculino , Metilaminas/análise , Metilaminas/metabolismo , Modelos Químicos , Ratos , Dióxido de Silício , Ácidos Sulfônicos/análise , TrítioAssuntos
Sulfametazina/sangue , Sulfatiazóis/sangue , Sulfisomidina/sangue , Administração Oral , Animais , Testes de Função Renal , Cinética , Masculino , Modelos Biológicos , Ligação Proteica , Coelhos , Sulfametazina/urina , Sulfatiazóis/urina , Sulfisomidina/urina , Fatores de Tempo , Água/administração & dosagem , Água/farmacologiaAssuntos
Compostos de Anilina/sangue , Naftalenos/sangue , Ácidos Sulfônicos/sangue , Aminas/administração & dosagem , Aminas/sangue , Aminas/urina , Compostos de Anilina/administração & dosagem , Compostos de Anilina/urina , Animais , Injeções Intravenosas , Inulina/administração & dosagem , Inulina/sangue , Cinética , Masculino , Modelos Biológicos , Naftalenos/administração & dosagem , Naftalenos/urina , Ligação Proteica , Coelhos , Ácidos Sulfônicos/administração & dosagem , Ácidos Sulfônicos/urina , Fatores de TempoRESUMO
Rats, with and without bile duct ligation (BDL), were injected with hexobarbital (i.p. and i.v.) and blood concentrations measured as a function of time. Analysis of these curves using a single-compartment model showed that BDL altered hexobarbital pharmacokinetics in a manner dependent upon the duration of BDL and the route of administration of hexobarbital. Clearance from the blood and the rate constant for elimination (K) were reduced after 72-hour BDL but not after 12-hour BDL. The absorption of hexobarbital after intraperitoneal injection was slowed by 12- and 72- hour BDL. Seventy-two-hour BDL also increased the volume of distribution of hexobarbital but only when the drug was administered intraperitoneally. These data are consistent with previously reported data showing impairment of hepatic microsomal drug metabolism after 72-hour BDL, but not after 12-hour BDL. We also confirmed earlier speculations that BDL decreased the absorption of intraperitoneally-administered hexobarbital, although this does not appear to be a significant factor in prolonging hexobarbital sleeping time.
Assuntos
Colestase/metabolismo , Hexobarbital/metabolismo , Animais , Ducto Colédoco , Injeções Intraperitoneais , Injeções Intravenosas , Ligadura , Masculino , RatosRESUMO
A three-way crossover study was performed to compare the bioavailability of a new pelletised doxycycline product administered either with food or without food and a reference product taken without food. Four different methods were used to calculate pharmacokinetic parameters from the data. The sums of squares, Akaike's Information Criterion (AIC), and the ranges for the parameters obtained were used for comparison. Good fits to the data were obtained when all four methods were used, each with a lag time. The two compartment open model was the most efficient method for describing the data. The one compartment open model was the least efficient, particularly with respect to predicting the peak concentration of doxycycline in plasma. All the models gave similar rank order results with respect to bioavailability differences between the three treatments. Analysis of the data by different methods suggests that pelletised doxycycline is bioequivalent to the reference product when taken in the absence of food. A standardized feeding regimen affected the rate, but not extent of absorption of doxycycline from the pelletised formulation.
Assuntos
Doxiciclina/farmacocinética , Absorção , Adulto , Disponibilidade Biológica , Preparações de Ação Retardada , Doxiciclina/sangue , Jejum/metabolismo , Alimentos , Humanos , Masculino , Modelos BiológicosRESUMO
In children, the blood level of phenytoin was found to be significantly higher when 100 mg capsules rather than 100 mg tablets were administered. When, on the other hand, 30 mg capsules and tablets were compared; the situation was reversed; tablets produced significantly higher blood levels of phenytoin than did the capsules. The significance and possible explantation of these findings are discussed.
Assuntos
Fenitoína/sangue , Adolescente , Disponibilidade Biológica , Cápsulas , Criança , Feminino , Humanos , Masculino , Fenitoína/administração & dosagem , Solubilidade , ComprimidosRESUMO
The weak binding of sugar substrates fails to induce any quantifiable physical changes in the L-fucose-H+ symport protein, FucP, from Escherichia coli, and this protein lacks any strongly binding ligands for competitive binding assays. Access to substrate binding behavior is however possible using NMR methods which rely on substrate immobiliza-tion for detection. Cross-polarization from proton to carbon spins could detect the portion of 13C-labeled substrate associated with 0.2 micromol of the functional transport system overexpressed in the native membranes. The detected substrate was shown to be in the FucP binding site because its signal was diminished by the unlabeled substrates L-fucose and L-galactose but was unaffected by a three- to fivefold molar excess of the non-transportable stereoisomer D-fucose. FucP appeared to bind both anomers of its substrates equally well. An NMR method, designed to measure the rate of substrate exchange, could show that substrate exchanged slowly with the carrier center (>10(-1) s), although its dynamics are not necessarily coupled strongly to this site within the protein. Relaxation measurements support this view that fluctuations in the interaction with substrate would be confined to the binding site in this transport system.
Assuntos
Proteínas de Transporte/química , Proteínas de Transporte/metabolismo , Proteínas de Escherichia coli , Espectroscopia de Ressonância Magnética/métodos , Simportadores , Proteínas de Bactérias/química , Proteínas de Bactérias/metabolismo , Sítios de Ligação , Ligação Competitiva , Fenômenos Biofísicos , Biofísica , Metabolismo dos Carboidratos , Escherichia coli/metabolismo , Fucose/metabolismo , Cinética , Ligantes , Ligação Proteica , TermodinâmicaRESUMO
A cross-over study was conducted to compare the plasma phenytoin levels produced by different phenytoin preparations available in Australia. The preparations were found not to be equivalent, a liquid suspension product producing higher levels compared with capsule and tablet formulations. The clinical significance and possible explantation are discussed.